Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Calcium homeostasis

Yorvipath

(palopegteriparatide)

Uses, side effects, dosage information & price range

Ascendis Pharma Bone Diseases A/S

About this medicine

Yorvipath is a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

MimparaComposition: cinacalcetAmgen Europe B.V.

Price on RequestView Details →

Cinacalcet Viatris (previously Cinacalcet Mylan)Composition: cinacalcetMylan Pharmaceuticals Limited

Price on RequestView Details →

TerrosaComposition: teriparatideGedeon Richter Plc.

Price on RequestView Details →

MovymiaComposition: teriparatideSTADA Arzneimittel AG

Price on RequestView Details →

Cinacalcet AccordpharmaComposition: cinacalcetAccord Healthcare S.L.U.

Price on RequestView Details →

Key Information

Salt / Composition

palopegteriparatide

Category

Calcium homeostasis

Manufacturer

Ascendis Pharma Bone Diseases A/S

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.